108. TNF receptor-associated periodic syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 44
TNF receptor-associated periodic syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 108 | TNF receptor-associated periodic syndrome | - |
| 267 | Hyper-IgD syndrome | 1.000 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.000 |
| 34 | Neurofibromatosis | 1.000 |
| 46 | Malignant rheumatoid arthritis | 1.000 |
| 51 | Scleroderma | 1.000 |
| 84 | Sarcoidosis | 1.000 |
| 85 | Idiopathic interstitial pneumonia | 1.000 |
| 222 | Primary nephrotic syndrome | 1.000 |
| 228 | Bronchiolitis obliterans | 1.000 |
| 113 | Muscular dystrophy | 1.000 |
| 50 | Dermatomyositis | 1.000 |
| 56 | Behcet disease | 1.000 |
| 107 | Juvenile idiopathic arthritis | 1.000 |
| 58 | Hypertrophic cardiomyopathy | 1.000 |
| 164 | Oculocutaneous albinism | 1.000 |
| 41 | Giant cell arteritis | 1.000 |
| 269 | Pyogenic arthritis | 1.000 |
| 106 | Cryopyrin-associated periodic syndrome | 1.000 |
| 266 | Familial mediterranean fever | 1.000 |